sinc
mani
case
fever
thrombocytopenia
leukopenia
syndrom
ftl
emerg
henan
provinc
china
patient
report
tick
bite
suggest
infect
could
contribut
ftl
mani
ticktransmit
microbi
pathogen
test
pcrrtpcr
andor
indirect
immunofluoresc
assay
ifa
howev
sampl
collect
test
posit
human
granulocyt
anaplasmosi
hga
suggest
pathogen
could
involv
use
unbias
metagenom
approach
screen
survey
microb
possibl
associ
ftl
blastx
analysi
deduc
protein
sequenc
reveal
novel
bunyaviru
ident
tehran
viru
access
present
sera
ftl
patient
phylogenet
analysi
show
although
close
relat
uukuniemi
viru
phleboviru
genu
viru
distinct
candid
viru
examin
associ
ftl
among
sampl
collect
henan
provinc
rtpcr
viral
cultur
seroepidemiolog
survey
undertaken
rtpcr
result
show
acutephas
serum
sampl
contain
viral
rna
patient
pair
acut
convalesc
sera
avail
serolog
evid
infect
seroconvers
exhibit
increas
antibodi
titer
viru
new
viru
isol
patient
acutephas
serum
sampl
name
henan
fever
viru
hnf
viru
wholegenom
sequenc
confirm
viru
novel
bunyaviru
genet
similar
known
bunyavirus
close
relat
uukuniemi
viru
maximum
ident
respect
segment
l
maximum
queri
coverag
releas
genbank
sequenc
sftsv
found
nearli
ident
ident
result
show
novel
bunyaviru
hnf
viru
strongli
correl
ftl
may
counti
hospit
xinyang
citi
henan
provinc
treat
three
patient
fever
abdomin
pain
bloat
nausea
vomit
gastrointestin
bleed
elev
aminotransferas
local
hospit
diagnos
diseas
acut
gastroenter
famili
member
one
patient
report
diseas
henan
center
diseas
control
prevent
cdc
sent
team
investig
investig
reveal
diseas
follow
characterist
acut
onset
fever
low
white
blood
cell
platelet
count
high
level
alanin
aspart
transaminas
posit
urin
protein
basi
featur
henan
cdc
exclud
possibl
gastrointestin
disord
order
identifi
diseas
etiolog
henan
cdc
team
use
clinic
characterist
case
definit
search
similar
case
local
hospit
neighbor
counti
establish
diseas
surveil
system
requir
medic
institut
report
case
met
case
definit
altogeth
case
found
henan
fatal
case
fatal
rate
patient
farmer
resid
mountain
hilli
villag
mani
report
tick
bite
day
ill
suggest
infecti
etiolog
recent
year
patient
similar
clinic
symptom
report
human
granulocyt
anaplasmosi
hga
anaplasma
phagocytophilum
neighbor
anhui
provinc
epidem
tsutsugamushi
scrub
typhu
orientia
tsutsugamushi
area
clinic
investig
epidemiolog
analys
laboratori
test
prompt
consider
rickettsi
diseas
possibl
caus
includ
hga
human
monocyt
ehrlichiosi
hme
ehrlichia
chaffeensi
tsutsugamushi
diseas
specif
method
polymeras
chain
reaction
pcr
immunofluoresc
assay
ifa
pathogen
use
determin
case
attribut
hga
hme
howev
patient
posit
phagocytophilum
base
serolog
dna
test
thu
diseas
initi
consid
least
partli
caus
phagocytophilum
case
provision
diagnos
suspect
hga
base
clinic
epidemiolog
data
year
sinc
suspect
case
discov
henan
low
posit
rate
phagocytophilum
confirm
patient
pathogen
isol
similar
case
also
report
mountain
hilli
area
nearbi
shandong
jiangsu
hubei
anhui
provinc
indic
diseas
alreadi
exist
time
wide
distribut
decid
address
possibl
caus
pathogen
underli
infect
basi
epidemiolog
clinic
characterist
consid
two
type
diseas
possibl
rickettsi
arthropodborn
viral
diseas
low
rate
phagocytophilum
rickettsi
diseas
detect
research
team
intensifi
viru
search
take
account
arthropodborn
virus
includ
flavivirida
dengu
virus
denv
japanes
enceph
viru
jev
togavirida
chikungunya
viru
eastern
equin
enceph
viru
eeev
western
equin
enceph
viru
bunyavirida
crimeancongo
hemorrhag
fever
viru
hantaan
viru
rift
valley
fever
viru
specif
pcr
assay
virus
use
howev
none
patient
posit
virus
suggest
new
infecti
agent
possibl
viru
remain
discov
thu
syndrom
consid
emerg
infecti
diseas
name
fever
thrombocytopenia
leukopenia
syndrom
ftl
identifi
etiolog
research
team
adopt
follow
strategi
sequenc
randomli
amplifi
cdna
dna
ftl
patient
sampl
use
highthroughput
illumina
sequenc
specif
explor
viral
commun
present
patient
suffer
ftl
pcr
detect
target
dna
directli
clinic
specimen
viral
cultur
immunodetect
method
electron
microscop
studi
morpholog
cultur
viru
cultur
follow
serolog
molecular
test
standard
approach
identifi
unknown
viru
howev
cultur
unknown
viru
timeconsum
even
take
sever
year
confirm
novel
infect
like
hiv
otherwis
viru
cultur
often
fail
lack
cell
line
capabl
support
propag
virus
eg
hepat
b
c
viru
method
clone
nucleic
acid
microbi
pathogen
directli
clinic
sampl
offer
opportun
pathogen
discoveri
therebi
lay
foundat
futur
studi
aim
assess
whether
novel
unexpect
virus
play
role
diseas
etiolog
random
pcr
subtract
clone
sequenc
identifi
previous
unknown
pathogen
etiolog
agent
sever
acut
chronic
infecti
diseas
recent
highthroughput
sequenc
approach
use
pathogen
detect
discoveri
clinic
sampl
also
develop
method
explor
virus
known
novel
use
highthroughput
illumina
sequenc
studi
highthroughput
illumina
sequenc
appli
specif
explor
viral
commun
patient
ftl
use
healthi
subject
control
provid
evid
discoveri
novel
bunyaviru
associ
ftl
highthroughput
sequenc
subsequ
cultur
viru
pcr
detect
specif
viru
patient
specimen
confirm
find
given
seriou
natur
ftl
decid
handl
clinic
specimen
perform
experi
involv
live
viru
biosafeti
facil
studi
henan
provinc
patient
ftl
whose
sampl
submit
henan
provinc
cdc
may
juli
acutephas
serum
sampl
patient
collect
pair
convalesc
sera
avail
patient
diagnost
test
sera
microbi
agent
possibl
relat
ftl
sera
test
revers
transcript
rt
pcr
pcr
indirect
ifa
serolog
assay
number
microbi
agent
includ
phagocytophilum
ehrlichia
chaffeensi
dengu
fever
viru
japanes
enceph
viru
chikungunya
viru
eastern
equin
enceph
viru
western
equin
enceph
viru
crimeancongo
hemorrhag
fever
viru
rift
valley
fever
viru
sandfli
fever
napl
sabin
viru
hantaviru
antigen
slide
diagnosi
hga
phagocytophilum
purchas
focu
diagnost
ca
usa
antigen
slide
diagnosi
pathogen
prepar
laboratori
fluorescein
isothiocyan
fitc
conjug
goat
antihuman
initi
case
lifethreaten
diseas
sudden
fever
thrombocytopenia
leukopenia
report
henan
provinc
china
patient
report
tick
bite
suggest
diseas
could
infecti
ticktransmit
mani
patient
provision
diagnos
human
granulocyt
anaplasmosi
hga
howev
object
evid
hga
suggest
pathogen
like
contribut
fever
thrombocytopenia
leukopenia
syndrom
ftl
illumina
sequenc
use
direct
detect
clinic
sampl
pathogen
possibl
associ
ftl
novel
bunyaviru
found
sampl
ftl
patient
epidemiolog
laboratori
investig
confirm
novel
bunyaviru
associ
ftl
result
illustr
metagenom
analysi
power
method
discoveri
novel
pathogen
agent
combin
epidemiolog
investig
could
assist
rapid
diagnosi
unknown
diseas
distinguish
diseas
similar
symptom
caus
known
pathogen
igg
fc
purchas
sihuan
scitechn
compani
beij
china
equal
quantiti
ml
acutephas
sera
ftl
patient
histori
tick
bite
pool
centrifug
x
g
minut
supernat
collect
dna
rna
extract
done
sera
healthi
subject
control
dna
extract
ml
sampl
use
qiaamp
dna
mini
kit
qiagen
accord
manufactur
instruct
dna
elut
column
ml
water
contain
mgml
rnasea
incub
minut
elimin
rna
dna
use
immedi
store
total
rna
extract
ml
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
rna
elut
column
ml
diethyl
pyrocarbon
depc
treat
water
contain
u
dnasei
sampl
incub
minut
elimin
human
dna
follow
dnase
inactiv
minut
rna
use
immedi
store
random
hexam
pcr
carri
mixtur
contain
ml
cdna
dna
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dntp
u
taq
dna
polymeras
promega
ng
random
hexam
primer
contain
linker
denatur
minut
target
amplifi
cycl
second
second
second
second
amplifi
product
detect
agaros
gel
electrophoresi
pure
water
use
neg
control
ftl
patient
control
genom
dnacdna
librari
construct
accord
manufactur
instruct
illumina
brief
rtpcr
pcr
product
roughli
quantifi
uv
absorpt
equal
amount
sampl
mix
nucleic
acid
within
mixtur
shear
sonic
fragment
rang
collect
cut
band
agaros
gel
electrophoresi
shear
dna
cdna
end
repair
use
klenow
dna
polymeras
termini
phosphoryl
termini
polyadenyl
adaptor
ad
pcr
enrich
perform
fragment
collect
sequenc
illumina
method
sequenc
procedur
perform
accord
manufactur
instruct
illumina
process
templat
librari
dna
hybrid
surfac
flow
cell
multipl
copi
dna
made
form
cluster
use
illumina
cluster
station
workflow
step
includ
templat
hybrid
isotherm
amplif
linear
final
denatur
hybrid
sequenc
primer
pairedend
sequenc
cycl
perform
use
fourcolor
dna
sequencingbysynthesi
sb
technolog
follow
manufactur
instruct
short
oligonucleotid
analysi
packag
soap
use
handl
larg
amount
short
read
gener
parallel
sequenc
briefli
filter
highli
repetit
sequenc
adaptor
sequenc
overlap
dataset
ftl
healthi
subject
analyz
subtract
fragment
map
host
genomicplustranscript
bacteria
databas
nonredund
read
map
onto
viru
databas
download
ncbi
ftp
ftpncbinihgov
genbank
result
align
filter
identifi
uniqu
sequenc
examin
align
ident
evalu
score
e
filter
uniqu
align
examin
taxonomi
databas
ncbi
use
custom
softwar
applic
written
perl
bioperl
version
unmap
read
examin
genbank
nucleic
acid
protein
databas
use
blastn
blastx
respect
uniqu
align
examin
taxonomi
databas
ncbi
sequenc
without
hit
place
unassign
categori
sequenc
phylotyp
human
bacteri
phage
viral
base
ident
best
blast
hit
consid
misannot
lowcomplex
illumina
short
read
sequenc
assign
viru
famili
assembl
contig
velvet
kmer
length
coverag
cutoff
default
insert
length
pe
minor
contig
length
direct
comparison
genbank
nucleic
acid
databas
use
blastn
contig
also
blast
genbank
protein
databas
use
blastx
evalu
cutoff
appli
blastn
blastx
analys
sequenc
phylotyp
viral
place
viral
categori
mass
sequenc
data
reveal
sequenc
show
possibl
infect
human
bocaviru
belong
parvovirida
famili
pcr
perform
detect
human
bocaviru
tent
identifi
sera
ftl
patient
sampl
amplifi
fragment
gene
describ
previous
amplifi
product
detect
agaros
gel
electrophoresi
sequenc
use
abi
dna
sequenc
mass
sequenc
data
reveal
sequenc
access
indic
possibl
presenc
novel
viru
closest
ident
ie
lowest
evalu
tehran
viru
belong
phleboviru
genu
bunyavirida
famili
develop
pcr
strategi
base
sequenc
identifi
sera
ftl
patient
sampl
detect
novel
bunyaviru
use
forward
pf
acg
ctc
ctc
aag
gct
revers
pr
cag
tag
ccc
tga
gtt
primer
design
supplementari
figur
pcr
carri
mixtur
contain
ml
cdna
mm
trishcl
ph
mm
kcl
mm
mgcl
mm
dntp
u
taq
pol
promega
mm
forward
primer
mm
revers
primer
thermocycl
condit
follow
minut
denatur
follow
cycl
second
second
second
amplifi
product
detect
agaros
gel
electrophoresi
sequenc
use
abi
dna
sequenc
vero
cell
line
african
green
monkey
kidney
cell
select
isol
novel
bunyaviru
associ
ftl
support
growth
mani
bunyavirus
vero
cell
line
inocul
six
serum
sampl
contain
novel
bunyaviru
rna
sampl
underw
least
three
cell
cultur
passag
vero
cell
line
consid
neg
medium
replenish
day
cultur
termin
day
inocul
cultur
observ
daili
cytopath
effect
cpe
virusinfect
cell
uninfect
cell
also
examin
novel
bunyaviru
rtpcr
passag
vero
cell
cultur
obviou
cpe
contain
novel
bunyaviru
rna
analyz
morpholog
genom
sequenc
serolog
cell
show
cpe
contain
novel
bunyaviru
rna
collect
thinsect
electron
microscopi
discard
cultur
supernat
virusinfect
cell
ml
mix
glutaraldehyd
paraformaldehyd
place
onto
formvarcarbonco
grid
stain
methylamin
tungstat
specimen
thinsect
electron
microscopi
prepar
dehydr
wash
cell
pellet
serial
dilut
aceton
embed
epoxi
resin
ultrathin
section
cut
ultracut
lkbv
ultramicrotom
stain
uranyl
acet
lead
citrat
examin
transmiss
electron
microscop
medium
ml
novel
bunyavirusinfect
vero
cell
centrifug
x
g
minut
x
g
minut
supernat
collect
ad
supernat
final
concentr
wv
follow
centrifug
x
g
hour
pellet
resuspend
ml
salin
pb
rna
extract
random
rtpcr
perform
product
bp
collect
ligat
pgemt
vector
promega
incub
overnight
escherichia
coli
transform
ligat
mixtur
cultur
lb
agar
contain
xgal
white
clone
sequenc
use
abi
dna
sequenc
contamin
human
extran
sequenc
elimin
use
crossmatch
complet
sequenc
assembl
use
phredphrapcons
bridg
rtpcr
employ
gapclosur
phylogenet
analys
perform
use
neighborjoin
method
mega
softwar
packag
version
avail
nucleotid
protein
sequenc
known
virus
obtain
genbank
inclus
phylogenet
tree
select
sequenc
genbank
includ
greatest
similar
sequenc
read
question
base
blast
align
well
repres
sequenc
major
taxa
within
relev
bunyavirida
famili
establish
relationship
new
viru
member
phlebovirus
genu
includ
sequenc
phlebovirus
avail
genbank
branch
order
phylogram
verifi
statist
resampl
data
time
bootstrap
analysi
branchandbound
algorithm
appli
mega
success
isol
novel
bunyaviru
develop
indirect
ifa
detect
specif
antibodi
patient
serum
specimen
previous
describ
brief
monolay
virusinfect
vero
cell
show
cpe
contain
novel
bunyaviru
rna
harvest
one
volum
infect
cell
mix
volum
noninfect
cell
mixtur
centrifug
x
g
minut
cell
resuspend
spot
onto
glass
slide
fix
aceton
minut
sera
patient
ftl
includ
acutephas
sampl
pair
sera
patient
respiratori
diseas
serum
sampl
healthi
subject
serum
sampl
appli
cell
sampl
dilut
pb
screen
first
spot
ml
serum
sampl
per
well
incub
minut
wash
minut
pb
ml
fitcconjug
goat
antihuman
igg
sihuan
scitechn
compani
beij
china
dilut
buffer
contain
evan
blue
ad
well
incub
minut
wash
slide
mount
glycerin
examin
immunofluoresc
microscopi
titer
consid
posit
median
age
patient
year
rang
maletofemal
ratio
patient
farmer
worker
student
among
patient
report
tick
bite
within
week
day
onset
clinic
manifest
remain
patient
recal
receiv
tick
bite
main
clinic
featur
confirm
patient
includ
sudden
onset
fever
last
day
fatigu
anorexia
headach
myalgia
arthralgia
dizzi
enlarg
lymph
node
muscl
ach
vomit
diarrhea
upper
abdomin
pain
rel
bradycardia
tabl
small
number
case
suffer
sever
complic
includ
hypotens
mental
statu
alter
ecchymosi
gastrointestin
hemorrhag
pulmonari
hemorrhag
respiratori
failur
dissemin
intravascular
coagul
multipl
organ
failur
andor
death
patient
good
outcom
elderli
patient
underli
diseas
neurolog
manifest
coagulopathi
hyponatremia
tend
poorer
outcom
laboratori
test
show
confirm
patient
characterist
develop
thrombocytopenia
leukopenia
proteinuria
elev
serum
aspart
aminotransferas
ast
alanin
aminotransferas
alt
level
tabl
biochem
test
reveal
gener
higher
level
lactat
dehydrogenas
creatin
kinas
ast
alt
enzym
especi
ast
one
lane
two
sampl
pool
ftl
healthi
control
consist
sampl
sequenc
proport
highqual
sequenc
ftl
control
pool
respect
uniqu
highqual
sequenc
read
classifi
broad
taxonom
group
base
taxonomi
frequent
topscor
blast
match
sequenc
viru
sequenc
constitut
read
ftl
control
librari
respect
tabl
contig
assembl
number
sequenc
phylotyp
viral
decreas
respect
two
pool
tabl
screen
possibl
virus
focus
exclus
virus
present
patient
sera
detect
known
virus
nonredund
read
directli
align
genbank
databas
nucleic
acid
use
blastn
softwar
sequenc
adenovirida
human
adenoviru
herpesvirida
herpesviru
papillomavirida
papillomaviru
retrovirida
human
endogen
retroviru
detect
ftl
patient
healthi
subject
sampl
hepat
b
viru
hbv
human
bocaviru
sequenc
detect
patient
sera
indic
presenc
hbv
human
bocaviru
infect
among
patient
detect
novel
virus
examin
sequenc
data
genbank
protein
databas
use
blastx
analysi
deduc
protein
sequenc
reveal
four
differ
viru
famili
sera
ftl
patient
tabl
among
virus
hepadnavirida
known
caus
ftl
torqu
teno
viru
ttv
anellovirida
report
associ
certain
inflammatori
state
known
transmit
arthropod
virus
parvovirida
famili
includ
human
bocaviru
could
caus
febril
ill
sign
ftl
although
human
bocavirus
known
transmit
arthropod
felin
panleukopenia
viru
parvoviru
strongli
suspect
transmit
arthropod
famili
parvovirida
sequenc
detect
ftl
sampl
also
assembl
protein
sequenc
deduc
includ
among
sampl
four
fragment
found
highli
homolog
human
bocaviru
one
fragment
show
greatest
similar
human
bocaviru
isol
ident
lowest
evalu
human
bocaviru
detect
pcr
pool
serum
sampl
one
individu
sampl
within
pool
test
posit
bocaviru
final
viru
famili
detect
sera
ftl
patient
bunyavirida
famili
contain
virus
known
caus
ftl
tick
bite
famili
bunyavirida
sequenc
detect
ftl
sampl
includ
fragment
ssegment
msegment
lsegment
fragment
assembl
protein
sequenc
deduc
among
novel
viru
fragment
fragment
access
polymeras
gene
show
greatest
similar
tehran
viru
ident
lowest
evalu
suggest
presenc
novel
viru
known
viru
whose
genom
yet
sequenc
accur
assess
genet
relationship
known
virus
construct
phylogenet
tree
use
neighborjoin
method
result
show
potenti
novel
viru
cluster
toscana
viru
uukuniemi
viru
rift
valley
fever
viru
phleboviru
genu
figur
pool
serum
sampl
patient
serum
sampl
healthi
subject
also
screen
pcr
presenc
novel
bunyaviru
sampl
patient
test
posit
novel
bunyaviru
howev
sampl
healthi
subject
test
neg
thu
focus
viru
famili
bunyavirida
use
specif
design
rtpcr
primer
detect
viral
rna
acut
serum
sampl
test
tabl
specif
rtpcr
confirm
sequenc
select
pcr
product
none
sera
patient
respiratori
diseas
sera
healthi
subject
posit
use
novel
virusspecif
rtpcr
six
acut
serum
sampl
test
posit
novel
bunyaviru
specif
rtpcr
inocul
onto
vero
cell
four
viru
strain
isol
initi
cpe
analysi
show
round
refractil
cell
day
inocul
cpe
progress
initi
cultur
appear
slightli
hour
subsequ
passag
figur
rtpcr
reveal
presenc
rna
novel
bunyaviru
four
viru
strain
isol
react
serum
convalesc
patient
ifa
figur
addit
electron
microscopi
show
presenc
viru
particl
approxim
nm
diametera
size
compat
bunyaviru
figur
viru
particl
presum
local
golgi
apparatu
figur
genom
sequenc
one
isol
reveal
three
segment
neg
polar
singlestrand
rna
includ
larg
segment
l
genbank
mediums
segment
genbank
small
segment
genbank
deduc
amino
acid
sequenc
l
segment
highest
homolog
e
valu
rna
polymeras
uukuniemi
viru
phleboviru
genu
wherea
segment
highest
homolog
e
valu
glycoprotein
gene
punta
toro
viru
phleboviru
genu
two
protein
encod
ambisens
segment
one
highest
homolog
nucleocapsid
protein
e
valu
rift
valley
fever
viru
highest
homolog
nonstructur
protein
gene
e
valu
puniqu
viru
belong
phleboviru
genu
collect
find
confirm
viru
belong
phleboviru
genu
bunyavirida
revis
manuscript
new
sequenc
sftsv
sever
fever
thrombocytopenia
syndrom
releas
comparison
new
sftsv
sequenc
sequenc
novel
viru
show
highli
homolog
ident
use
sequenc
phleboviru
avail
genbank
phylogenet
analysi
show
although
close
relat
uukuniemi
viru
phleboviru
genu
maximum
ident
respect
segment
l
maximum
queri
coverag
three
genom
segment
novel
viru
along
sftsv
sequenc
highli
diverg
figur
igg
antibodi
novel
bunyaviru
detect
acutephas
serum
sampl
patient
ftl
tabl
patient
pair
acuteand
convalescentphas
sera
avail
seroconvers
greater
increas
antibodi
titer
viru
six
less
increas
antibodi
titer
viru
pair
sera
test
posit
sixteen
patient
test
neg
viru
suggest
nonftl
patient
similar
symptom
includ
studi
situat
surpris
given
ftl
newli
emerg
diseas
acutephas
sera
four
patient
viru
isol
test
neg
igg
antibodi
viru
convalesc
sera
obtain
month
later
four
patient
contain
igg
antibodi
viru
none
sera
patient
respiratori
diseas
healthi
subject
detect
antibodi
sinc
increas
report
case
ftl
xinyang
citi
henan
provinc
patient
tent
diagnos
phagocytophilum
infect
howev
patient
evid
phagocytophilum
infect
none
patient
test
posit
mani
pathogen
capabl
caus
similar
clinic
laboratori
manifest
also
investig
find
suggest
novel
infecti
agent
includ
virus
tradit
viru
cultur
import
identifi
unknown
viral
infect
perform
illumina
sequenc
strategi
attempt
viral
rickettsi
cultur
bhk
cell
line
lack
obviou
cpe
led
us
initi
abandon
approach
mass
sequenc
data
obtain
illumina
sequenc
reveal
four
viru
famili
appear
ftl
patient
sera
among
four
viru
famili
virus
parvovirida
bunyavirida
famili
reportedli
caus
sign
ftl
transmit
arthropod
howev
one
sampl
pool
ten
sampl
test
posit
bocaviru
pcr
suggest
bocaviru
parvovirida
like
involv
ftl
virus
bunyavirida
famili
incid
infect
close
link
vector
activ
exampl
tickborn
virus
common
late
spring
late
summer
tick
activ
peak
human
infect
certain
bunyavirida
crimeancongo
hemorrhag
fever
viru
associ
high
level
morbid
mortal
consid
tickbit
histori
mani
ftl
patient
focus
bunyavirida
famili
virus
entir
bunyavirida
famili
contain
member
arrang
four
genera
arthropodborn
virus
orthobunyaviru
nairoviru
phleboviru
tospoviru
one
genu
hantaviru
rodentborn
virus
phleboviru
genu
current
compris
antigen
distinct
serotyp
studi
known
serotyp
divid
two
group
phlebotomu
fever
group
sandfli
group
transmit
phlebotomina
sandfli
compris
member
uukuniemi
group
transmit
tick
compris
remain
member
serotyp
eight
link
diseas
human
includ
alenqu
candiru
chagr
napl
punta
toro
rift
valley
fever
sicilian
toscana
virus
phlebovirus
tripartit
genom
consist
larg
l
medium
small
rna
segment
screen
unknown
virus
speci
hit
alon
like
carri
littl
weight
thu
use
sequenc
famili
bunyavirida
analysi
fragment
polymeras
gene
lowest
evalu
high
sequenc
ident
use
sequenc
unknown
viru
viru
sequenc
detect
pool
sampl
indic
viru
involv
ftl
detect
possibl
novel
bunyaviru
highthroughput
illumina
sequenc
inocul
vero
cell
line
known
sensit
phlebovirus
sera
six
posit
patient
subsequ
abl
detect
viru
rtpcr
although
cpe
modest
rtpcr
confirm
infect
genom
sequenc
perform
phylogenet
analysi
genom
sequenc
show
viru
cluster
phleboviru
branch
diverg
known
phlebovirus
result
confirm
novelti
viru
within
phleboviru
genu
famili
bunyavirida
furthermor
viru
size
propag
cell
similar
bunyavirus
pcr
serolog
test
perform
test
causal
link
new
viru
ftl
although
complet
fulfil
koch
postul
evid
implic
new
bunyaviru
outbreak
diseas
among
patient
ftl
compel
view
fact
diseas
caus
novel
bunyaviru
take
account
diseas
first
discov
henan
hn
propos
name
henan
fever
ftl
diseas
caus
novel
viru
propos
name
henan
fever
viru
hnf
viru
sinc
submiss
manuscript
bunyaviru
identifi
caus
ftl
chines
patient
region
china
author
name
viru
sftsv
indic
caus
sever
fever
thrombocytopenia
syndrom
releas
genbank
sequenc
refer
yu
paper
compar
sequenc
sftsv
ftlsv
found
nearli
ident
ident
first
identifi
syndrom
describ
presenc
viru
patient
suggest
name
hnf
viru
take
preced
distinct
featur
current
work
includ
use
unbias
metagenom
approach
viral
pathogen
discoveri
facilit
rapid
creation
implement
standard
cultur
serolog
molecular
diagnost
approach
howev
differ
result
describ
report
yu
et
al
notabl
observ
slight
distinct
cpe
vero
cell
reason
failur
observ
cpe
vero
cell
infect
sftsv
bunyaviru
whose
genom
nearli
ident
bunyaviru
isol
ftl
patient
unclear
perhap
reflect
fact
ensu
cpe
dramat
altern
could
indic
exist
distinct
viral
strain
vari
pathogen
virul
possibl
even
diseas
manifest
area
activ
studi
laboratori
discoveri
new
viru
assist
rapid
diagnosi
diseas
help
distinguish
diseas
caus
pathogen
phagocytophilum
e
chaffeensi
crimeancongo
hemorrhag
fever
viru
hantaviru
dengu
viru
japanes
enceph
viru
chikungunya
viru
furthermor
avail
new
viru
facilit
futur
develop
new
therapeut
intervent
vaccin
drug
figur
sensit
dynam
rang
realtim
pcr
detect
bunyaviru
rna
evalu
sensit
rtpcr
realtim
pcr
perform
serial
dilut
vitrobtranscrib
bunyaviru
rna
sequenc
test
wide
linear
rang
copi
copi
control
rna
per
reaction
detect
assay
tif
